(Q34156627)

31 July 2017

title

Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent (English)

1 reference

31 July 2017

1 reference

1 reference

Alain Patat

1

1 reference

31 July 2017

Isabelle Paty

series ordinal

2

1 reference

31 July 2017

Ian Hindmarch

series ordinal

3

1 reference

31 July 2017

publication date

1 July 2001

1 reference

31 July 2017

published in

Human Psychopharmacology

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

369-392

1 reference

Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

31 July 2017

cites work

1 reference

The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers.

21 January 2018

1 reference

Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats

21 January 2018

1 reference

High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors

21 January 2018

1 reference

Comparison of the daytime sleep and performance effects of zolpidem versus triazolam

21 January 2018

1 reference

Association of road-traffic accidents with benzodiazepine use.

21 January 2018

1 reference

A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.

21 January 2018

1 reference

Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo

21 January 2018

1 reference

Prevalence of sleep disorders in the Los Angeles metropolitan area

21 January 2018

1 reference

Residual effects of flunitrazepam

21 January 2018

1 reference

Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults

21 January 2018

1 reference

Science and the environment--challenges, risks, and the future

21 January 2018

1 reference

Evaluation of severe insomnia in the general population: results of a European multinational survey

21 January 2018

1 reference

Tranquillising memories: a review of the effects of benzodiazepines on human memory

21 January 2018

1 reference

Benzodiazepines, memory and mood: a review

21 January 2018

1 reference

Proposed research diagnostic criteria for neuroleptic malignant syndrome

21 January 2018

1 reference

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

21 January 2018

1 reference

Segregation of HLA genes in multicase narcolepsy families

21 January 2018

1 reference

Pharmacotherapy of insomnia: practice and prospects

21 January 2018

1 reference

Zaleplon: a review of its use in the treatment of insomnia

21 January 2018

1 reference

Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia

21 January 2018

1 reference

Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.

21 January 2018

1 reference

Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic

21 January 2018

1 reference

The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers

21 January 2018

1 reference

Pharmacokinetics of the newer benzodiazepines

21 January 2018

1 reference

Dose-response analysis of the behavioral effects of diazepam: I. Learning and memory

21 January 2018

1 reference

Drug therapy: The diagnosis and management of insomnia

21 January 2018

1 reference

Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic

21 January 2018

1 reference

Residual and acute effects of flurazepam and triazolam in normal subjects

21 January 2018

1 reference

Pharmacokinetics of Benzodiazepine Hypnotics

21 January 2018

1 reference

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

21 January 2018

1 reference

Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam

21 January 2018

1 reference

Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group

21 January 2018

1 reference

Psychomotor function and psychoactive drugs

21 January 2018

1 reference

Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening

21 January 2018

1 reference

Prevalence and treatment of insomnia in general practice. A longitudinal study.

21 January 2018

1 reference

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

Rebound Insomnia and Rebound Anxiety: A Review

21 January 2018

1 reference

Prevalence of sleep disturbance in a primarily urban Florida County

21 January 2018

1 reference

Benzodiazepines and vigilance performance: a review

21 January 2018

1 reference

Residual effects of repeated doses of 0.5 and 1 mg flunitrazepam.

21 January 2018

1 reference

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

21 January 2018

1 reference

Chronic use of benzodiazepines and psychomotor and cognitive test performance

21 January 2018

1 reference

Insomnia and its treatment. Prevalence and correlates.

21 January 2018

1 reference

An assessment of short-acting hypnotics

21 January 2018

1 reference

Selective effects of zolpidem on human memory functions

21 January 2018

1 reference

Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers

21 January 2018

1 reference

Hypnotic activity of an imidazo-pyridine (zolpidem).

21 January 2018

1 reference

Activity of the hypnotics, flunitrazepam and triazolam, in man

21 January 2018

1 reference

Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy

21 January 2018

1 reference

Zopiclone's residual effects on psychomotor and information processing skills involved in complex tasks such as car driving: a critical review

21 January 2018

1 reference

Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.

21 January 2018

1 reference

Diazepam impairs lateral position control in highway driving.

21 January 2018

1 reference

Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.

21 January 2018

1 reference

Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia

21 January 2018

1 reference

EEG profile of intravenous zolpidem in healthy volunteers

21 January 2018

1 reference

gamma-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site

21 January 2018

1 reference

Type I and type II GABAA-benzodiazepine receptors produced in transfected cells

21 January 2018

1 reference

Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers

21 January 2018

1 reference

Psychotropic drug use and the risk of hip fracture

21 January 2018

1 reference

Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers

21 January 2018

1 reference

Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers

21 January 2018

1 reference

Sedative, memory, and performance effects of hypnotics

21 January 2018

1 reference

Effects of zaleplon or triazolam with or without ethanol on human performance

21 January 2018

1 reference

The effects of flurazepam, lorazepam, and triazolam on sleep and memory

21 January 2018

1 reference

Behavioral pharmacology of zolpidem relative to benzodiazepines: a review

21 January 2018

1 reference

Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

21 January 2018

1 reference

Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

21 January 2018

1 reference

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

21 January 2018

1 reference

The Pharmacology and Mechanism of Action of Zolpidem

21 January 2018

1 reference

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

21 January 2018

1 reference

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem

21 January 2018

1 reference

Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold

21 January 2018

1 reference

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

21 January 2018

1 reference

Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic

21 January 2018

1 reference

Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia

21 January 2018

1 reference

Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia

21 January 2018

1 reference

A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia

21 January 2018

1 reference

The morbidity of insomnia uncomplicated by psychiatric disorders

21 January 2018

1 reference

Effects of daytime administration of zolpidem versus triazolam on memory

21 January 2018

1 reference

Effects of benzodiazepines on psychomotor performance

21 January 2018

1 reference

The socioeconomic impact of insomnia. An overview

21 January 2018

1 reference

Impact of insomnia on health-related quality of life

21 January 2018

1 reference

Sleep disturbance. A component of health status.

21 January 2018

1 reference

Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades

21 January 2018

1 reference

7 January 2021

Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders--recognition, epidemiology, and rational management

1 reference

7 January 2021

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group

1 reference

7 January 2021

Sleep complaints among elderly persons: an epidemiologic study of three communities.

1 reference

7 January 2021

Effects of hypnotics on memory

1 reference

7 January 2021

Kinetics of five benzodiazepine hypnotics in healthy subjects

1 reference

7 January 2021

Management of insomnia

1 reference

7 January 2021

A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers

1 reference

7 January 2021

Pharmacological treatment of insomnia

1 reference

7 January 2021

Residual effects of hypnotics: triazolam, flurazepam, and nitrazepam

1 reference

7 January 2021

Clinical pharmacology of psychotropic drugs

1 reference

7 January 2021

Zaleplon pharmacokinetics and absolute bioavailability

1 reference

7 January 2021

Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects?A review

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.310

1 reference

31 July 2017

1 reference